Article 6. Powers of the Ministry of Health of the Republic of Uzbekistan in the field of medicines and pharmaceutical activity

The Ministry of Health of the Republic of Uzbekistan shall:

participate in the development and implementation of state programs in the field of medicines and pharmaceutical activity;

form a state order for medicines included in the list of essential medicines, as well as for medical products, and ensure control over their availability in state medical institutions;

carry out licensing of pharmaceutical activity (except retail sale of ophthalmological medical products (optics)) in the prescribed manner;

ensure the preferential provision of certain categories of persons with medicines in the manner established by the Cabinet of Ministers of the Republic of Uzbekistan;

approve normative legal acts in the field of medicines and medical products, as well as normative documents in the field of technical regulation;

approve and publish the State Pharmacopoeia;

ensure state registration, quality control, standardization, and certification of medicines, medical products, and medical equipment in the prescribed manner;

establish the procedure for sale, distribution, storage, and accounting of narcotic drugs, psychotropic substances, and precursors permitted for use in medical practice, as well as for sale, storage, and accounting of ethyl alcohol;

maintain and periodically publish the state register of medicines, medical products, and medical equipment permitted for use in medical practice;

suspend the production, preparation, import, and sale of medicines and medical products in cases where facts confirming their harmful effects are available. Suspension of production and preparation of medicines and medical products leading to suspension of business activity (except cases of suspension for not more than ten working days to prevent emergencies, epidemics, and other real threats to life and health of the population) shall be carried out by court procedure;

carry out pharmacological control;

develop and approve the list of orphan medicines intended for the treatment of rare diseases, as well as the list of medical products intended for the diagnosis and treatment of rare (orphan) diseases;